510(k) K042808
K042808 is an FDA 510(k) premarket notification submitted by Bayer Healthcare, LLC for the device "ADVIA IMS CARBAMAZEPINE METHOD". The FDA issued a decision of Substantially Equivalent on Feb 8, 2005. The device falls under product code KLT (Enzyme Immunoassay, Carbamazepine), a Class II device regulated under 21 CFR 862.3645. Bayer Healthcare, LLC has 54 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 8, 2005
- Date Received
- Oct 12, 2004
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Carbamazepine
- Device Class
- Class II
- Regulation Number
- 862.3645
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Bayer Healthcare, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.